158 related articles for article (PubMed ID: 7862184)
21. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
22. Cushing's disease.
Aron DC; Findling JW; Tyrrell JB
Endocrinol Metab Clin North Am; 1987 Sep; 16(3):705-30. PubMed ID: 2826137
[TBL] [Abstract][Full Text] [Related]
23. [Test of pituitary adrenal restraining with IV dexamethasone in the diagnosis of Cushing's syndrome (author's transl)].
Linquette M; Cappoen JP; Fourlinnie JC; Harpignies G
Sem Hop; 1980 Sep 18-25; 56(33-36):1380-4. PubMed ID: 6252630
[TBL] [Abstract][Full Text] [Related]
24. Cushing's Syndrome: Where and How to Find It.
Debono M; Newell-Price JD
Front Horm Res; 2016; 46():15-27. PubMed ID: 27211887
[TBL] [Abstract][Full Text] [Related]
25. Case 53-1981: Cushing's syndrome.
N Engl J Med; 1982 May; 306(20):1239-40. PubMed ID: 6280050
[No Abstract] [Full Text] [Related]
26. Cushing's syndrome.
Boscaro M; Barzon L; Fallo F; Sonino N
Lancet; 2001 Mar; 357(9258):783-91. PubMed ID: 11253984
[TBL] [Abstract][Full Text] [Related]
27. Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment.
Sonino N; Fava GA
CNS Drugs; 2001; 15(5):361-73. PubMed ID: 11475942
[TBL] [Abstract][Full Text] [Related]
28. Cushing's syndrome--1988.
Sheeler LR
Cleve Clin J Med; 1988; 55(4):329-37. PubMed ID: 2842087
[No Abstract] [Full Text] [Related]
29. Psychosomatic aspects of Cushing's syndrome.
Sonino N; Fallo F; Fava GA
Rev Endocr Metab Disord; 2010 Jun; 11(2):95-104. PubMed ID: 19960264
[TBL] [Abstract][Full Text] [Related]
30. Evaluation and Treatment of Patients With Hypercortisolism: A Review.
Miller BS; Auchus RJ
JAMA Surg; 2020 Dec; 155(12):1152-1159. PubMed ID: 33052413
[TBL] [Abstract][Full Text] [Related]
31. Clinical problem-solving: localizing the source of ectopic corticotropin.
Lastowiecki P
N Engl J Med; 1994 Sep; 331(12):814. PubMed ID: 8065426
[No Abstract] [Full Text] [Related]
32. [Endocrine diseases: progress in diagnosis and treatments. Topics: I. Anterior lobes of the pituitary; 2. Cushing syndrome].
Kageyama K; Nigawara T; Daimon M
Nihon Naika Gakkai Zasshi; 2014 Apr; 103(4):832-40. PubMed ID: 24908979
[No Abstract] [Full Text] [Related]
33. A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states.
Papanicolaou DA; Yanovski JA; Cutler GB; Chrousos GP; Nieman LK
J Clin Endocrinol Metab; 1998 Apr; 83(4):1163-7. PubMed ID: 9543134
[TBL] [Abstract][Full Text] [Related]
34. A case of gallbladder neuroendocrine carcinoma complicated by ectopic adrenocorticotropic hormone syndrome and resulting in rapid fetal outcomes due to sepsis.
Sato K; Suzuki T; Akaike K; Uchihara D; Ichii O; Tai M; Takagi T; Hakozaki H; Ejiri Y
Clin J Gastroenterol; 2024 May; ():. PubMed ID: 38773001
[TBL] [Abstract][Full Text] [Related]
35. Changes of androgen and corticosterone metabolites excretion and conversion in cystic fibrosis.
Podgórski R; Sumińska M; Rachel M; Pikuła B; Fichna P; Bidlingmaier M; Fichna M
Front Endocrinol (Lausanne); 2023; 14():1244127. PubMed ID: 37711888
[TBL] [Abstract][Full Text] [Related]
36. Genetically predicted plasma cortisol and common chronic diseases: A Mendelian randomization study.
Lee WH; Larsson SC; Wood A; Di Angelantonio E; Butterworth AS; Burgess S; Allara E
Clin Endocrinol (Oxf); 2024 Mar; 100(3):238-244. PubMed ID: 37667866
[TBL] [Abstract][Full Text] [Related]
37. Alteration in glucocorticoids secretion and metabolism in patients affected by cystic fibrosis.
Podgórski R; Sumińska M; Rachel M; Fichna M; Fichna P; Mazur A
Front Endocrinol (Lausanne); 2022; 13():1074209. PubMed ID: 36568105
[TBL] [Abstract][Full Text] [Related]
38. In Situ Metabolomics of Cortisol-Producing Adenomas.
Murakami M; Sun N; Li F; Feuchtinger A; Gomez-Sanchez C; Fassnacht M; Reincke M; Bancos I; Walch A; Kroiss M; Beuschlein F
Clin Chem; 2023 Feb; 69(2):149-159. PubMed ID: 36544353
[TBL] [Abstract][Full Text] [Related]
39. 11β-HSD as a New Target in Pharmacotherapy of Metabolic Diseases.
Kupczyk D; Bilski R; Kozakiewicz M; Studzińska R; Kędziora-Kornatowska K; Kosmalski T; Pedrycz-Wieczorska A; Głowacka M
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012251
[TBL] [Abstract][Full Text] [Related]
40. The Effect of Weight-Loss Interventions on Cervical and Chin Subcutaneous Fat Depots; the CENTRAL Randomized Controlled Trial.
Tsaban G; Bilitzky-Kopit A; Yaskolka Meir A; Zelicha H; Gepner Y; Shelef I; Orr O; Chassidim Y; Sarusi B; Ceglarek U; Stumvoll M; Blüher M; Stampfer MJ; Shai I; Schwarzfuchs D
Nutrients; 2021 Oct; 13(11):. PubMed ID: 34836081
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
